반응식
[CH3:1][C:2]1[CH:7]=[C:6]([CH3:8])[CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][N:12]([C:15]([C:17]2[CH:22]=[CH:21][C:20](I)=[CH:19][CH:18]=2)=[O:16])[CH2:11][CH2:10]1.[O:24]1[CH2:28][CH2:27][NH:26][C:25]1=[O:29]>>[CH3:1][C:2]1[CH:7]=[C:6]([CH3:8])[CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][N:12]([C:15]([C:17]2[CH:22]=[CH:21][C:20]([N:26]3[CH2:27][CH2:28][O:24][C:25]3=[O:29])=[CH:19][CH:18]=2)=[O:16])[CH2:11][CH2:10]1참가 물질
3
실험 절차
By reaction and treatment in the same manner as in Example 1 and using [4-(2,4-dimethylphenyl)piperazin-1-yl](4-iodophenyl)methanone (7.7 g) described in Preparation Example 8 and oxazolidin-2-one (1.6 g), the title compound (4 g) was obtained.
후처리
- customBy reaction and treatment in the same manner as in Example 1
출처 및 근거
- ORD 기록
- ord-8a7122117b0a4ca081e95aa50d0b5534
- 출처 데이터셋
- uspto-grants-2013_01
- 특허 번호
- US08354401B2
연결된 노트
불러오는 중…